Legend Biotech Corp (LEGN) Capital expenditures 2018–2025
Legend Biotech Corp (LEGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$28.6MFY2025 · since FY2018: $21.0M → $28.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $28.6M | +102.8% |
| FY2024 | $14.1M | -29.9% |
| FY2023 | $20.1M | -4.0% |
| FY2022 | $20.9M | -50.4% |
| FY2021 | $42.2M | +60.7% |
| FY2020 | $26.3M | -1.9% |
| FY2019 | $26.8M | +27.7% |
| FY2018 | $21.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice